CN Patent

CN114096264B — 制备psma缀合物的方法

Assigned to Indoset Co ltd · Expires 2025-03-14 · 1y expired

What this patent protects

本披露内容涉及制备用于治疗哺乳动物疾病如癌症的化合物的方法。特别地，本文所述的发明涉及制备能够靶向表达PSMA的细胞，并且可用于治疗由表达PSMA的细胞引起的疾病如前列腺癌的化合物的方法。

USPTO Abstract

本披露内容涉及制备用于治疗哺乳动物疾病如癌症的化合物的方法。特别地，本文所述的发明涉及制备能够靶向表达PSMA的细胞，并且可用于治疗由表达PSMA的细胞引起的疾病如前列腺癌的化合物的方法。

Drugs covered by this patent

pafolacianine-sodium (PAFOLACIANINE SODIUM)

Patent Metadata

Patent number: CN114096264B
Jurisdiction: CN
Classification: —
Expires: 2025-03-14
Drug substance claim: No
Drug product claim: No
Assignee: Indoset Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.